5 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 3 with minor changes only.
Primary completion pushed from Jul 31, 2026 to Oct 22, 2027
Also in this update: Primary endpoint(s) modified; Study completion pushed from Dec 31, 2026 to Oct 22, 2030
RenJi HospitalPhase 2 NCT05831891 Registry history of NCT05831891 on ClinicalTrials.gov (opens the registry)
Updated
Primary endpoint(s) modified
Also in this update: Trial completed; Final enrollment: 1518 participants (planned 1000)
RenJi HospitalNot specified NCT04698304 Registry history of NCT04698304 on ClinicalTrials.gov (opens the registry)
Updated
Interventions modified
RenJi HospitalNot applicable NCT07622199 Registry history of NCT07622199 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
RenJi HospitalNot specified NCT06642129 Registry history of NCT06642129 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
RenJi HospitalNot applicable NCT06187896 Registry history of NCT06187896 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07874542 Plasma DNA Methylation for Preoperative Classification of Renal Masses | Recruiting | |
| 2026-10-02 | NCT07854197 Effect of Remimazolam on Hypoxemia and/or Hypotension in Prostate Biopsy | Not Yet Recruiting | |
| 2026-09-22 | NCT07833046 Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With… | Not Yet Recruiting |
| Early Phase 1 | 5 | |
| Phase 1 | 5 | |
| Phase 1/2 | 2 | |
| Phase 2 | 28 | |
| Phase 2/3 | 4 | |
| Phase 3 | 5 | |
| Phase 4 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06754371 | Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage | Postpartum Hemorrhage | Recruiting | 2025-03-17 |
| NCT06353126 | DEB-TACE Prior to Liver Transplantation in the Treatment of HCC | Liver Cancer | Recruiting | 2024-10-18 |
| NCT07696208 | Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for… | Hemodynamic Stability | Not Yet Recruiting | 2026-07-10 |
| NCT06645275 | Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A… | Anticoagulation | Not Yet Recruiting | 2024-10-16 |
| NCT06476301 | Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With… | Anticoagulation | Not Yet Recruiting | 2024-06-28 |
| Phase 3 | ||||
| NCT05910398 | Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive… | Breast Cancer Invasive | Recruiting | 2025-11-18 |
| NCT04254263 | Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer | Locally Advanced Breast Cancer | Recruiting | 2025-09-11 |
| NCT03201861 | Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk… | Tubular Breast Cancer | Recruiting | 2025-05-16 |
| NCT07030621 | Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular… | Acute Ischemic Stroke | Not Yet Recruiting | 2025-06-22 |
| NCT06314698 | Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease | Multiple Myeloma | Not Yet Recruiting | 2024-03-18 |
| Phase 2/3 | ||||
| NCT06851663 | Trop2-targeted immunoPET Imaging of Solid Tumors | Solid Tumor | Recruiting | 2026-05-29 |
| NCT06972511 | Maximal Tumor Eradication for Oligometastatic Prostate Cancer | Oligometastatic Prostate Cancer | Recruiting | 2025-05-15 |
| NCT06653465 | Intravenous Acetaminophen for Postoperative Delirium in Older Patients Recovering From… | Delirium in Old Age | Not Yet Recruiting | 2025-04-04 |
| NCT02221999 | Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative… | Tubular Breast Cancer | Active, Not Recruiting | 2023-08-29 |
| Phase 2 | ||||
| NCT07283692 | Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT) | Triple Negative Breast Cancer | Recruiting | 2026-05-13 |
| NCT07396324 | Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer | HR-positive/HER2-negative Breast Cancer | Recruiting | 2026-05-13 |
| NCT06852638 | CD70-targeted immunoPET Imaging of Malignant Cancers | Renal Cancer | Recruiting | 2026-05-12 |
| NCT06680089 | CD70-targeted immunoPET Imaging of Kidney Cancer | Urologic Neoplasms | Recruiting | 2025-12-31 |
| NCT05912816 | Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients | Upper Urinary Tract Urothelial Carcinoma | Recruiting | 2025-12-09 |
| NCT06091124 | Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma | Neuroendocrine Carcinoma of the Bladder | Recruiting | 2025-12-08 |
| NCT06978933 | FGF19 Overexpression Combination Unified Study in HCC-19 | HCC - Hepatocellular Carcinoma | Recruiting | 2025-05-18 |
| NCT06652906 | Study on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in… | Physical Examination | Recruiting | 2024-10-22 |
| NCT03392233 | Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors | Breast Cancer | Recruiting | 2018-01-05 |
| NCT05831891 | Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal… | Non-clear Cell Renal Cell Carcinoma | Active, Not Recruiting | 2026-09-16 |
| NCT07730151 | Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant… | Prostate Cancer | Not Yet Recruiting | 2026-07-28 |
Breast Cancer (17) · Heart Disease (11) · Kidney Cancer (11) · Bladder Cancer (10) · Liver Cancer (10) · Prostate Cancer (8) · Pancreatic Cancer (7) · Colorectal Cancer (5) · Esophageal Cancer (5) · Lung Cancer (5)